ID   DHB12_HUMAN             Reviewed;         312 AA.
AC   Q53GQ0; A8K9B0; D3DR23; Q96EA9; Q96JU2; Q9Y6G8;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   02-OCT-2007, sequence version 2.
DT   10-MAY-2017, entry version 126.
DE   RecName: Full=Very-long-chain 3-oxoacyl-CoA reductase {ECO:0000305};
DE            EC=1.1.1.330 {ECO:0000269|PubMed:12482854};
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase 12 {ECO:0000303|PubMed:16166196};
DE            Short=17-beta-HSD 12 {ECO:0000303|PubMed:16166196};
DE   AltName: Full=3-ketoacyl-CoA reductase {ECO:0000303|PubMed:12482854};
DE            Short=KAR {ECO:0000303|PubMed:12482854};
DE   AltName: Full=Estradiol 17-beta-dehydrogenase 12 {ECO:0000303|PubMed:16166196};
DE            EC=1.1.1.62 {ECO:0000269|PubMed:16166196};
DE   AltName: Full=Short chain dehydrogenase/reductase family 12C member 1;
GN   Name=HSD17B12 {ECO:0000312|HGNC:HGNC:18646}; Synonyms=SDR12C1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Liu T., Zhang J., Fu G., Zhang Q., Ye M., Zhou J., Wu J., Shen Y.,
RA   Yu M., Chen S., Mao M., Chen Z.;
RT   "Human steroid dehydrogenase homologue, complete cds.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-280.
RC   TISSUE=Liver, Placenta, Thymus, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-280.
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-280.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 26-35; 65-72; 104-117; 157-179 AND 207-221, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (JUN-2005) to UniProtKB.
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=12482854; DOI=10.1074/jbc.M211684200;
RA   Moon Y.-A., Horton J.D.;
RT   "Identification of two mammalian reductases involved in the two-carbon
RT   fatty acyl elongation cascade.";
RL   J. Biol. Chem. 278:7335-7343(2003).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=16113833; DOI=10.1267/THRO05020412;
RA   Gnatenko D.V., Cupit L.D., Huang E.C., Dhundale A., Perrotta P.L.,
RA   Bahou W.F.;
RT   "Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases.
RT   Distinct profiles predict the essential thrombocythemic phenotype.";
RL   Thromb. Haemost. 94:412-421(2005).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF VAL-196 AND PHE-234.
RX   PubMed=16166196; DOI=10.1210/me.2005-0058;
RA   Luu-The V., Tremblay P., Labrie F.;
RT   "Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an
RT   isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for
RT   estradiol formation in women.";
RL   Mol. Endocrinol. 20:437-443(2006).
RN   [11]
RP   INTERACTION WITH ELOVL1 AND LASS2.
RX   PubMed=20937905; DOI=10.1073/pnas.1005572107;
RA   Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y.,
RA   Sassa T., Kihara A.;
RT   "ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid
RT   synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18439-18444(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the second of the four reactions of the long-
CC       chain fatty acids elongation cycle. This endoplasmic reticulum-
CC       bound enzymatic process, allows the addition of two carbons to the
CC       chain of long- and very long-chain fatty acids/VLCFAs per cycle.
CC       This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3-
CC       ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid
CC       elongation. Thereby, it may participate in the production of
CC       VLCFAs of different chain lengths that are involved in multiple
CC       biological processes as precursors of membrane lipids and lipid
CC       mediators. May also catalyze the transformation of estrone (E1)
CC       into estradiol (E2) and play a role in estrogen formation.
CC       {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16166196}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain (3R)-3-hydroxyacyl-CoA +
CC       NADP(+) = a very-long-chain 3-oxoacyl-CoA + NADPH.
CC       {ECO:0000269|PubMed:12482854}.
CC   -!- CATALYTIC ACTIVITY: 17-beta-estradiol + NAD(P)(+) = estrone +
CC       NAD(P)H. {ECO:0000269|PubMed:16166196}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.5 uM for estrone {ECO:0000269|PubMed:16166196};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:12482854}.
CC   -!- PATHWAY: Steroid biosynthesis; estrogen biosynthesis.
CC       {ECO:0000269|PubMed:16166196}.
CC   -!- SUBUNIT: Interacts with ELOVL1 and LASS2.
CC       {ECO:0000269|PubMed:20937905}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=2; IntAct=EBI-2963255, EBI-6863754;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-2963255, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-2963255, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12482854}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12482854}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q53GQ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q53GQ0-2; Sequence=VSP_056380, VSP_056381;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues tested. Highly
CC       expressed in the ovary and mammary. Expressed in platelets.
CC       {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16113833,
CC       ECO:0000269|PubMed:16166196}.
CC   -!- DOMAIN: The di-lysine motif confers endoplasmic reticulum
CC       localization for type I membrane proteins. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. 17-beta-HSD 3 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK027882; Type=Frameshift; Positions=92; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF078850; AAD44482.1; -; mRNA.
DR   EMBL; AK027882; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK074952; BAG52039.1; -; mRNA.
DR   EMBL; AK075216; BAG52086.1; -; mRNA.
DR   EMBL; AK222881; BAD96601.1; -; mRNA.
DR   EMBL; AK292625; BAF85314.1; -; mRNA.
DR   EMBL; AC023085; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068205; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087521; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68082.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68087.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68088.1; -; Genomic_DNA.
DR   EMBL; BC012043; AAH12043.1; -; mRNA.
DR   EMBL; BC012536; AAH12536.1; -; mRNA.
DR   CCDS; CCDS7905.1; -. [Q53GQ0-1]
DR   RefSeq; NP_057226.1; NM_016142.2. [Q53GQ0-1]
DR   UniGene; Hs.132513; -.
DR   ProteinModelPortal; Q53GQ0; -.
DR   SMR; Q53GQ0; -.
DR   BioGrid; 119328; 43.
DR   IntAct; Q53GQ0; 17.
DR   STRING; 9606.ENSP00000278353; -.
DR   ChEMBL; CHEMBL5998; -.
DR   SwissLipids; SLP:000000433; -.
DR   iPTMnet; Q53GQ0; -.
DR   PhosphoSitePlus; Q53GQ0; -.
DR   SwissPalm; Q53GQ0; -.
DR   BioMuta; HSD17B12; -.
DR   DMDM; 158931120; -.
DR   EPD; Q53GQ0; -.
DR   MaxQB; Q53GQ0; -.
DR   PaxDb; Q53GQ0; -.
DR   PeptideAtlas; Q53GQ0; -.
DR   PRIDE; Q53GQ0; -.
DR   DNASU; 51144; -.
DR   Ensembl; ENST00000278353; ENSP00000278353; ENSG00000149084. [Q53GQ0-1]
DR   Ensembl; ENST00000395700; ENSP00000379052; ENSG00000149084. [Q53GQ0-2]
DR   GeneID; 51144; -.
DR   KEGG; hsa:51144; -.
DR   UCSC; uc001mxq.5; human. [Q53GQ0-1]
DR   CTD; 51144; -.
DR   DisGeNET; 51144; -.
DR   GeneCards; HSD17B12; -.
DR   HGNC; HGNC:18646; HSD17B12.
DR   HPA; HPA016427; -.
DR   MIM; 609574; gene.
DR   neXtProt; NX_Q53GQ0; -.
DR   OpenTargets; ENSG00000149084; -.
DR   PharmGKB; PA38618; -.
DR   eggNOG; KOG1014; Eukaryota.
DR   eggNOG; COG0300; LUCA.
DR   GeneTree; ENSGT00390000010069; -.
DR   HOGENOM; HOG000039237; -.
DR   HOVERGEN; HBG005478; -.
DR   InParanoid; Q53GQ0; -.
DR   KO; K10251; -.
DR   OMA; MNMNKST; -.
DR   OrthoDB; EOG091G06T2; -.
DR   PhylomeDB; Q53GQ0; -.
DR   TreeFam; TF314591; -.
DR   BRENDA; 1.1.1.62; 2681.
DR   Reactome; R-HSA-193048; Androgen biosynthesis.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   SABIO-RK; Q53GQ0; -.
DR   UniPathway; UPA00094; -.
DR   UniPathway; UPA00769; -.
DR   ChiTaRS; HSD17B12; human.
DR   GeneWiki; HSD17B12; -.
DR   GenomeRNAi; 51144; -.
DR   PRO; PR:Q53GQ0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149084; -.
DR   CleanEx; HS_HSD17B12; -.
DR   ExpressionAtlas; Q53GQ0; baseline and differential.
DR   Genevisible; Q53GQ0; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:Ensembl.
DR   GO; GO:0102339; F:3-oxo-arachidoyl-CoA reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102340; F:3-oxo-behenoyl-CoA reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102342; F:3-oxo-cerotoyl-CoA reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0102341; F:3-oxo-lignoceroyl-CoA reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005518; F:collagen binding; IEA:Ensembl.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0016509; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0006703; P:estrogen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000126; 11-beta-HSD1; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   NADP; Oxidoreductase; Polymorphism; Reference proteome;
KW   Steroid biosynthesis; Transmembrane; Transmembrane helix.
FT   CHAIN         1    312       Very-long-chain 3-oxoacyl-CoA reductase.
FT                                /FTId=PRO_0000248368.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TRANSMEM    182    202       Helical. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical. {ECO:0000255}.
FT   NP_BIND      50     79       NADP. {ECO:0000250}.
FT   MOTIF       308    312       Di-lysine motif.
FT   ACT_SITE    202    202       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING     189    189       Substrate. {ECO:0000250}.
FT   VAR_SEQ      95     98       KEKF -> SNYT (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056380.
FT   VAR_SEQ      99    312       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056381.
FT   VARIANT     280    280       S -> L (in dbSNP:rs11555762).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_027277.
FT   MUTAGEN     196    196       V->W: No effect.
FT                                {ECO:0000269|PubMed:16166196}.
FT   MUTAGEN     234    234       F->A: Allows the conversion of
FT                                androstenedione to testosterone.
FT                                {ECO:0000269|PubMed:16166196}.
SQ   SEQUENCE   312 AA;  34324 MW;  8518336D7F514E50 CRC64;
     MESALPAAGF LYWVGAGTVA YLALRISYSL FTALRVWGVG NEAGVGPGLG EWAVVTGSTD
     GIGKSYAEEL AKHGMKVVLI SRSKDKLDQV SSEIKEKFKV ETRTIAVDFA SEDIYDKIKT
     GLAGLEIGIL VNNVGMSYEY PEYFLDVPDL DNVIKKMINI NILSVCKMTQ LVLPGMVERS
     KGAILNISSG SGMLPVPLLT IYSATKTFVD FFSQCLHEEY RSKGVFVQSV LPYFVATKLA
     KIRKPTLDKP SPETFVKSAI KTVGLQSRTN GYLIHALMGS IISNLPSWIY LKIVMNMNKS
     TRAHYLKKTK KN
//
